1. Ito J, Suzuki R, Uriu K, Itakura Y, Zahradnik J, Kimura KT, Deguchi S, Wang L, Lytras S, Tamura T, Kida I, Nasser H, Shofa M, Begum MM, Tsuda M, Oda Y, Suzuki T, Sasaki J, Sasaki-Tabata K, Fujita S, Yoshimatsu K, Ito H, Nao N, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Kuramochi J, Schreiber G; Genotype to Phenotype Japan (G2P-Japan) Consortium; Saito A, Matsuno K, Takayama K, Hashiguchi T, Tanaka S,Fukuhara T, Ikeda T, Sato K.Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.Nat Commun.2023,14,1,2671,doi:10.1038/s41467-023-38188-z.
2. Tamura T, Yamasoba D, Oda Y, Ito J, Kamasaki T, Nao N, Hashimoto R, Fujioka Y, Suzuki R, Wang L, Ito H, Kashima Y, Kimura I, Kishimoto M, Tsuda M, Sawa H, Yoshimatsu K, Yamamoto Y, Nagamoto T, Kanamune J, Suzuki Y, Ohba Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Yokota I, Matsuno K, Takayama K, Tanaka S, Sato K,Fukuhara T.Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.Commun Biol.2023,6,1,772,doi:10.1038/s42003-023-05081-w.
3. Kimura I, Yamasoba D, Nasser H, Ito H, Zahradnik J, Wu J, Fujita S, Uriu K, Sasaki J, Tamura T, Suzuki R, Deguchi S, Plianchaisuk A, Yoshimatsu K, Kazuma Y, Mitoma S, Schreiber G, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Takaori-Kondo A; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Shirakawa K, Takayama K, Irie T, Hashiguchi T, Nakagawa S,Fukuhara T, Saito A, Ikeda T, Sato K.Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.J Virol.2023,97,10,doi:10.1128/jvi.01011-23.
4. Daichi Yamasoba‡, Keiya Uriu‡, Arnon Plianchaisuk‡, Yusuke Kosugi‡, Lin Pan‡, Jiri Zahradnik, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jumpei Ito & Kei Sato*. Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant. Lancet Infectious Diseases 23(6):655-656, 2023. ‡Equal contribution; *Corresponding author.
5. Tamura, T., Ito, H., Torii, S., Wang, L., Suzuki, R., Tsujino, S., Kamiyama, A., Oda, Y., Tsuda, M., Morioka, Y., Suzuki, S., Shirakawa, K., Sato, K., Yoshimatsu, K., Matsuura, Y., Iwano, S., Tanaka, S., Fukuhara, T. Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection, ISCIENCE (2024), doi: https://doi.org/10.1016/j.isci.2024.109647.
6. Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K,Fukuhara T.Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.Nat Commun.2024,15,1,1176,doi:10.1038/s41467-024-45274-3.